#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	550	CRP	633	633	99.37	CRP.l15.c4.ctg.1	1062	27.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	328	330	ACG	31;30;34	A;C;G	31;30;33	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	550	CRP	633	633	99.37	CRP.l15.c4.ctg.1	1062	27.9	0	.	p	.	0	T209S	NONSYN	625	627	ACT	868	870	TCT	27;25;26	T;C;T	26;25;26	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2068	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1407	72.8	1	SNP	p	R234F	1	.	.	700	702	TTC	896	898	TTC	94;92;92	T;T;C	94;91;90	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2068	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1407	72.8	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1196	1198	CGT	87;89;87	C;G;T	86;89;86	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2068	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1407	72.8	0	HET	.	.	.	T999C	.	999	999	T	1195	1195	T	83	T,C	43,40	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2068	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1407	72.8	0	HET	.	.	.	C255T	.	255	255	C	451	451	C	72	C,T	37,35	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2068	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1407	72.8	0	HET	.	.	.	C144T	.	144	144	C	340	340	C	54	C,T	35,18	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	179	2068	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1407	72.8	0	HET	.	.	.	T180C	.	180	180	T	376	376	T	63	T,C	33,25	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	722	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1717	22.5	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1531	1533	AAA	10;10;10	A;A;A	10;10;10	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1072	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1612	35.2	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1229	1231	GAA	25;25;24	G;A;A	25;25;24	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	216	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	781	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	774	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1466	28.3	0	.	p	.	0	H2R	NONSYN	4	6	CAT	194	196	CGT	28;27;27	C;G;T	28;27;26	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	774	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1466	28.3	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1037	1039	GGC	37;36;36	G;G;C	37;36;35	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1126	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1968	30.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	186	188	AGC	12;12;13	A;G;C	12;12;13	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1126	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1968	30.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	588	590	CTA	33;35;34	C;T;A	33;35;34	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1126	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1968	30.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1107	1109	CAA	46;48;49	C;A;A	46;48;49	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1126	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1968	30.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1206	1208	GGT	46;45;45	G;G;T	46;45;45	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1126	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1968	30.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1776	1778	GTT	27;26;24	G;T;T	27;26;24	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	442	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1380	16.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	522	524	GAA	22;22;22	G;A;A	22;22;22	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	442	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1380	16.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	702	704	ACC	15;15;14	A;C;C	15;15;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	442	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1380	16.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	822	824	ACT	4;3;3	A;C;T	4;3;3	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	442	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1380	16.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1212	1214	ATC	12;13;13	A;T;C	12;12;13	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	568	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1377	22.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	60	TEM_1+	858	242	98.35	TEM_1+.l15.c30.ctg.1	242	3.9	0	.	p	.	0	F19L	NONSYN	55	57	TTT	30	32	CTT	5;5;5	C;T;T	3;3;3	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	60	TEM_1+	858	242	98.35	TEM_1+.l15.c30.ctg.1	242	3.9	0	.	p	.	0	V82I	NONSYN	244	246	GTT	219	221	ATT	3;3;3	A;T;T	3;3;3	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	60	TEM_1+	858	362	99.17	TEM_1+.l15.c30.ctg.2	364	3.3	0	.	p	.	0	H162R	NONSYN	484	486	CAT	106	108	CGT	2;2;2	C;G;T	2;2;2	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1950	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3475	30.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	456	458	ATC	32;31;30	A;T;C	32;31;30	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1950	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3475	30.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2169	2171	AAG	18;18;21	A;A;G	17;18;21	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	842	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1562	29.1	0	.	p	.	0	A22V	NONSYN	64	66	GCC	265	267	GTC	5;4;5	G;T;C	5;4;5	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	842	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1562	29.1	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1006	1008	TGC	45;46;46	T;G;C	45;46;46	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2108	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3343	33.4	0	.	p	.	0	S46trunc	TRUNC	136	136	T	199	199	T	19	T	19	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2108	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3343	33.4	0	.	p	.	0	G148D	NONSYN	442	444	GGC	505	507	GAC	43;42;42	G;A;C	43;42;42	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2108	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3343	33.4	0	.	p	.	0	F240L	NONSYN	718	720	TTT	781	783	TTA	19;19;19	T;T;A	19;19;19	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2108	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3343	33.4	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1858	1860	AAT	31;32;32	A;A;T	31;32;32	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2108	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3343	33.4	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1972	1974	AGT	30;30;31	A;G;T	30;30;31	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2108	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3343	33.4	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2371	2373	GTG	39;38;37	G;T;G	39;38;37	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2108	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3343	33.4	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2926	2928	AAG	35;36;36	A;A;G	35;36;36	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	454	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1116	21.9	1	SNP	p	R45C	0	.	.	133	135	CGC	392	394	CGC	28;27;27	C;G;C	28;27;27	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	420	acrS	663	663	98.79	acrS.l15.c4.ctg.1	881	25.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	125	127	TTC	21;21;21	T;T;C	21;21;21	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	420	acrS	663	663	98.79	acrS.l15.c4.ctg.1	881	25.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	389	391	GGG	31;31;31	G;G;G	31;31;31	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	564	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1184	25.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	629	631	CTT	35;34;35	C;T;T	35;34;35	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2008	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3067	35.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2045	2047	GCA	53;53;52	G;C;A	53;52;52	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2008	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3067	35.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2306	2308	ACC	36;38;38	A;C;C	36;38;38	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2008	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3067	35.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2615	2617	GCC	34;34;35	G;C;C	33;33;35	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	1010	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1794	26.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	27	29	GTT	19;21;21	G;T;T	19;21;21	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	1010	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1794	26.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	177	179	CAC	11;11;11	C;A;C	11;11;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	1010	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1794	26.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	462	464	ATG	35;35;33	A;T;G	34;35;33	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	1010	arnA_1	1983	1560	98.72	arnA_1.l15.c4.ctg.1	1794	26.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1458	1460	CGC	25;25;25	C;G;C	25;25;25	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	1010	arnA_1	1983	372	96.51	arnA_1.l15.c4.ctg.2	372	12.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	62	64	GCT	6;6;8	G;C;T	6;6;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	1010	arnA_1	1983	372	96.51	arnA_1.l15.c4.ctg.2	372	12.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	182	184	GAG	7;7;6	G;A;G	7;7;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	1010	arnA_1	1983	372	96.51	arnA_1.l15.c4.ctg.2	372	12.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	218	220	TGC	6;6;8	T;G;C	6;6;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	408	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1072	19.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	878	880	ACC	9;9;10	A;C;C	9;9;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	408	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1072	19.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	890	892	TCG	13;13;13	T;C;G	13;13;13	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	426	baeR	723	723	97.65	baeR.l15.c4.ctg.1	1067	21.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	718	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1502	24.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1209	1211	AAA	15;16;16	A;A;A	13;16;16	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	718	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1502	24.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1221	1223	GAG	11;12;11	G;A;G	11;12;11	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	718	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1502	24.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1227	1229	CAC	13;13;14	C;A;C	12;13;14	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	718	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1502	24.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1281	1283	GAG	12;12;11	G;A;G	12;12;11	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	970	cpxA	1374	1374	98.91	cpxA.l15.c17.ctg.1	1585	32.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	584	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1075	29.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	520	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1358	20.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	634	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1215	26.3	0	.	p	.	0	W42C	NONSYN	124	126	TGG	153	155	TGT	14;14;15	T;G;T	14;14;15	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	634	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1215	26.3	0	.	p	.	0	I219V	NONSYN	655	657	ATC	684	686	GTC	39;40;39	G;T;C	37;38;39	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1184	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	1871	33.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	864	emrD	1191	1191	98.57	emrD.l6.c30.ctg.1	1579	29.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	819	821	AGC	24;24;22	A;G;C	24;24;22	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	22	emrE_1	333	93	96.77	emrE_1.l15.c4.ctg.2	123	4.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	524	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1511	18.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	737	739	AGG	17;17;18	A;G;G	17;17;18	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	524	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1511	18.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1127	1129	GAC	13;13;13	G;A;C	13;13;13	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	404	emrR	531	531	100.0	emrR.l15.c4.ctg.1	965	22.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	834	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1942	23.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	292	evgA	615	615	99.19	evgA.l15.c4.ctg.1	889	16.8	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	262	264	CTG	18;18;19	C;T;G	18;18;19	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	293	295	ATA	7;7;7	A;T;A	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	305	307	GTA	9;9;9	G;T;A	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	458	460	ACG	17;18;20	A;C;G	17;18;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	521	523	GAA	17;18;18	G;A;A	17;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	560	562	GCT	23;25;25	G;C;T	23;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	578	580	GAT	21;20;20	G;A;T	21;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	665	667	TCA	21;22;22	T;C;A	21;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	794	796	CAG	19;19;18	C;A;G	19;19;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	932	934	GTT	17;18;18	G;T;T	17;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1088	1090	GAT	2;1;1	G;A;T	2;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1256	1258	AAT	9;9;8	A;A;T	9;9;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1277	1279	TTA	2;2;2	T;T;A	2;2;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1478	1480	AAA	12;12;12	A;A;A	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2213	2215	CAT	20;20;20	C;A;T	20;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2267	2269	CAT	17;17;17	C;A;T	17;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2285	2287	AGA	18;18;20	A;G;A	18;18;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2300	2302	AAT	23;23;23	A;A;T	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2447	2449	TCC	18;19;19	T;C;C	18;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2612	2614	ATT	19;20;20	A;T;T	19;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2633	2635	GAT	19;19;18	G;A;T	19;19;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2747	2749	GTT	25;24;24	G;T;T	25;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3032	3034	CAC	28;28;27	C;A;C	28;28;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1568	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3936	21.3	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	3770	3772	AAC	11;11;13	A;A;C	11;11;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	478	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1260	20.4	1	SNP	p	P64S	0	.	.	190	192	CCA	384	386	CCA	43;45;43	C;C;A	43;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	478	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1260	20.4	1	SNP	p	P64R	0	.	.	190	192	CCA	384	386	CCA	43;45;43	C;C;A	43;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	478	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1260	20.4	1	SNP	p	P64A	0	.	.	190	192	CCA	384	386	CCA	43;45;43	C;C;A	43;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	478	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1260	20.4	1	SNP	p	P64L	0	.	.	190	192	CCA	384	386	CCA	43;45;43	C;C;A	43;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	478	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1260	20.4	1	SNP	p	P64H	0	.	.	190	192	CCA	384	386	CCA	43;45;43	C;C;A	43;44;43	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	372	gadE	528	528	100.0	gadE.l15.c30.ctg.1	942	21.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	132	96.97	gadW.l15.c4.ctg.1	132	19.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	184	93.48	gadW.l15.c4.ctg.2	185	7.0	0	.	p	.	0	D100E	NONSYN	298	300	GAC	6	8	GAA	1;1;1	G;A;A	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	184	93.48	gadW.l15.c4.ctg.2	185	7.0	0	.	p	.	0	P101S	NONSYN	301	303	CCC	9	11	TCC	1;1;1	T;C;C	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	184	93.48	gadW.l15.c4.ctg.2	185	7.0	0	.	p	.	0	R102G	NONSYN	304	306	CGG	12	14	GGG	1;1;1	G;G;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	184	93.48	gadW.l15.c4.ctg.2	185	7.0	0	.	p	.	0	K110N	NONSYN	328	330	AAA	36	38	AAT	5;6;6	A;A;T	5;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	19.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	168	170	TTA	20;19;19	T;T;A	20;19;19	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	19.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	246	248	ATT	15;15;15	A;T;T	15;15;15	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	19.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	747	749	GGA	14;14;14	G;G;A	14;14;14	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	394	gadX	825	825	97.94	gadX.l15.c4.ctg.1	999	19.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	753	755	CCG	14;14;14	C;C;G	14;14;14	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3057	34.1	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	454	456	TTG	29;28;28	T;T;G	28;26;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3057	34.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2239	2241	GAA	48;48;50	G;A;A	48;48;50	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3057	34.1	1	SNP	p	D87G	0	.	.	259	261	GAC	466	468	GAC	26;23;23	G;A;C	24;22;23	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3057	34.1	1	SNP	p	D87N	0	.	.	259	261	GAC	466	468	GAC	26;23;23	G;A;C	24;22;23	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3057	34.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	466	468	GAC	26;23;23	G;A;C	24;22;23	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3057	34.1	1	SNP	p	D87V	0	.	.	259	261	GAC	466	468	GAC	26;23;23	G;A;C	24;22;23	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1938	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3057	34.1	1	SNP	p	D87H	0	.	.	259	261	GAC	466	468	GAC	26;23;23	G;A;C	24;22;23	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1766	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2831	33.6	1	SNP	p	R136G	0	.	.	406	408	CGC	602	604	CGC	29;28;29	C;G;C	29;28;29	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1766	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2831	33.6	1	SNP	p	R136E	0	.	.	406	408	CGC	602	604	CGC	29;28;29	C;G;C	29;28;29	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1766	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2831	33.6	1	SNP	p	R136L	0	.	.	406	408	CGC	602	604	CGC	29;28;29	C;G;C	29;28;29	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1766	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2831	33.6	1	SNP	p	R136S	0	.	.	406	408	CGC	602	604	CGC	29;28;29	C;G;C	29;28;29	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1766	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2831	33.6	1	SNP	p	R136H	0	.	.	406	408	CGC	602	604	CGC	29;28;29	C;G;C	29;28;29	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1766	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2831	33.6	1	SNP	p	R136I	0	.	.	406	408	CGC	602	604	CGC	29;28;29	C;G;C	29;28;29	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1766	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2831	33.6	1	SNP	p	R136C	0	.	.	406	408	CGC	602	604	CGC	29;28;29	C;G;C	29;28;29	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	382	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	989	20.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	379	381	CCG	24;25;24	C;C;G	24;25;23	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	382	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	989	20.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	532	534	GCC	24;23;23	G;C;C	24;23;23	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	692	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1303	28.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	176	178	TCA	29;31;31	T;C;A	29;31;31	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	272	marA	384	384	99.74	marA.l15.c17.ctg.1	784	18.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	331	333	AGC	9;9;9	A;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	433	435	CAT	3;3;3	C;A;T	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	V45E	0	.	.	133	135	GTG	157	159	GTG	12;12;12	G;T;G	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	I49S	0	.	.	145	147	ATC	169	171	ATC	12;12;12	A;T;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	A70T	0	.	.	208	210	GCA	232	234	GCA	15;15;15	G;C;A	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	R73S	0	.	.	217	219	CGT	241	243	CGT	14;13;13	C;G;T	14;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	R73C	0	.	.	217	219	CGT	241	243	CGT	14;13;13	C;G;T	14;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	R77C	0	.	.	229	231	CGC	253	255	CGC	14;14;16	C;G;C	14;14;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	R77L	0	.	.	229	231	CGC	253	255	CGC	14;14;16	C;G;C	14;14;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	L78M	0	.	.	232	234	CTG	256	258	CTG	15;14;13	C;T;G	15;14;13	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	R94S	0	.	.	280	282	CGC	304	306	CGC	9;9;9	C;G;C	9;8;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	R94H	0	.	.	280	282	CGC	304	306	CGC	9;9;9	C;G;C	9;8;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	116	marR	435	432	97.69	marR.l15.c4.ctg.1	456	10.6	1	SNP	p	V96E	0	.	.	286	288	GTA	310	312	GTA	8;8;8	G;T;A	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	S7F	NONSYN	19	21	TCC	43	45	TTC	9;9;9	T;T;C	9;8;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	R36I	NONSYN	106	108	AGG	130	132	ATC	14;14;12	A;T;C	14;14;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	E42A	NONSYN	124	126	GAA	148	150	GCC	3;3;3	G;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	N43V	NONSYN	127	129	AAT	151	153	GTG	3;3;3	G;T;G	2;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	E52D	NONSYN	154	156	GAG	178	180	GAT	6;6;6	G;A;T	6;5;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	N59T	NONSYN	175	177	AAC	199	201	ACC	3;3;3	A;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	I68L	NONSYN	202	204	ATA	226	228	TTA	9;7;7	T;T;A	9;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	367	369	CAG	26;26;26	C;A;G	26;26;26	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	D128A	NONSYN	382	384	GAC	406	408	GCC	17;16;17	G;C;C	17;16;17	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	S163A	NONSYN	487	489	TCG	511	513	GCG	11;11;12	G;C;G	10;11;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	L231V	NONSYN	691	693	CTT	715	717	GTT	16;16;16	G;T;T	10;15;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	518	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1450	18.6	0	.	p	.	0	R285fs	FSHIFT	853	853	C	877	877	C	15	C	15	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	568	mdtA	1248	975	97.85	mdtA.l15.c17.ctg.1	1045	21.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	22	24	ATG	9;9;11	A;T;G	9;9;11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	568	mdtA	1248	975	97.85	mdtA.l15.c17.ctg.1	1045	21.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	115	117	ACC	12;12;12	A;C;C	11;12;12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	568	mdtA	1248	245	96.33	mdtA.l15.c17.ctg.2	385	16.9	0	.	p	.	0	V12trunc	TRUNC	34	34	G	180	180	G	28	G	28	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	568	mdtA	1248	245	96.33	mdtA.l15.c17.ctg.2	385	16.9	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	237	239	CAG	12;12;13	C;A;G	12;12;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1924	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3449	29.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1967	1969	ACC	29;30;29	A;C;C	29;29;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1924	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3449	29.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2360	2362	CAA	29;29;29	C;A;A	29;29;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1924	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3449	29.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2528	2530	ATT	23;22;22	A;T;T	23;22;22	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1924	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3449	29.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2612	2614	GTT	28;28;29	G;T;T	27;28;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1924	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3449	29.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2720	2722	GAG	23;24;23	G;A;G	23;24;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1924	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3449	29.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2948	2950	ATG	15;15;15	A;T;G	15;15;15	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1924	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3449	29.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3083	3085	GAT	23;23;24	G;A;T	22;23;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1960	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3312	31.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	350	352	ATG	21;20;18	A;T;G	20;19;17	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1960	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3312	31.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	836	838	ATC	30;32;31	A;T;C	29;31;31	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1960	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3312	31.5	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3152	3154	CAC	5;5;4	C;A;C,A	5;5;3,1	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1798	23.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	164	166	GAA	12;12;12	G;A;A	12;12;12	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1798	23.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	833	835	GCG	32;32;34	G;C;G	32;32;33	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1798	23.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1175	1177	ATC	29;29;29	A;T;C	29;27;28	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1798	23.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1478	1480	TTT	14;14;15	T;T;T	14;14;15	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	944	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1549	32.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2382	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3523	36.3	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1090	1092	ACC	31;31;31	A;C,A;C	31;28,1;31	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2382	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3523	36.3	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2332	2334	GAC	48;48;49	G;A;C	48;48;49	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	696	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1441	22.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	610	612	ATC	25;25;25	A;T;C	25;25;25	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	696	mdtG	1227	176	99.43	mdtG.l15.c4.ctg.3	177	15.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	7	9	GGA	1;1;1	G;G;A	1;1;1	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	604	mdtH	1209	1207	98.18	mdtH.l15.c30.ctg.2	1262	24.3	0	.	p	.	0	G134C	NONSYN	400	402	GGT	398	400	TGT	27;28;30	T;G;T	27;28;30	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	604	mdtH	1209	1207	98.18	mdtH.l15.c30.ctg.2	1262	24.3	0	.	p	.	0	S324L	NONSYN	970	972	TCG	968	970	TTG	20;21;22	T;T;G	20;21;22	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	604	mdtH	1209	1207	98.18	mdtH.l15.c30.ctg.2	1262	24.3	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1178	1180	ACG	12;12;12	A;C;G	12;12;12	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	746	mdtL	1176	1176	98.21	mdtL.l6.c30.ctg.1	1550	25.7	0	.	p	.	0	A185S	NONSYN	553	555	GCC	739	741	TCC	30;31;30	T;C;C	28;31;30	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	560	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1253	22.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	530	532	ATT	25;24;23	A;T;T	25;24;22	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1374	mdtO	2052	2052	97.51	mdtO.l6.c17.ctg.1	2328	31.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	173	175	ATG	19;18;18	A;T;G	18;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1374	mdtO	2052	2052	97.51	mdtO.l6.c17.ctg.1	2328	31.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	239	241	ATC	31;31;31	A;T,C;C	31;29,1;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1374	mdtO	2052	2052	97.51	mdtO.l6.c17.ctg.1	2328	31.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	488	490	CGC	37;37;37	C;G;C	37;37;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1374	mdtO	2052	2052	97.51	mdtO.l6.c17.ctg.1	2328	31.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	854	856	AGC	32;33;34	A;G;C	31;32;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1374	mdtO	2052	2052	97.51	mdtO.l6.c17.ctg.1	2328	31.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1055	1057	GTG	21;24;24	G;T;G	21;23;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1374	mdtO	2052	2052	97.51	mdtO.l6.c17.ctg.1	2328	31.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1118	1120	AAC	14;14;14	A;A;C	14;12;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	1374	mdtO	2052	2052	97.51	mdtO.l6.c17.ctg.1	2328	31.4	0	.	p	.	0	P330fs	FSHIFT	988	988	C	1130	1130	C	17	C	17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	384	384	T	47	T,C	46,1	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	567	569	GCG	21;21;19	G;C;G	21;21;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	741	743	ACC	22;23;24	A,G;C;C	21,1;23;24	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	813	815	CGC	20;21;23	C;G;C	20;21;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	930	932	GCT	24;22;22	G;C;T	24;22;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1014	1016	AAA	18;18;17	A;A;A	18;17;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1032	1034	CGA	24;24;25	C;G;A	24;24;25	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1197	1199	GCC	31;30;29	G;C;C	30;30;29	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1209	1211	GAT	36;37;40	G;A;T	36;37;40	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	890	mdtP	1467	1467	97.89	mdtP.l6.c17.ctg.1	1846	25.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1626	1628	GCT	12;12;12	G;C;T	12;12;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2120	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3853	29.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1501	1503	AAG	24;23;23	A;A;G	24;23;23	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2120	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3853	29.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2578	2580	CTG	36;37;37	C;T;G	36;36;37	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	126	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	329	15.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1250	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2000	33.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1006	1008	AAC	24;24;24	A;A;C	24;24;23	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1250	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2000	33.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1552	1554	ATA	32;33;33	A;T;A	32;33;33	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	978	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1652	31.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1301	1303	GAT	38;38;40	G;A;T	38;38;40	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	978	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1652	31.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1304	1306	CTG	40;42;41	C;T;G	40;42;41	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	313	99.04	nfsA.l15.c30.ctg.1	582	15.9	0	.	p	.	0	R27C	NONSYN	79	81	CGT	153	155	TGT	18;18;18	T;G;T	18;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	313	99.04	nfsA.l15.c30.ctg.1	582	15.9	1	SNP	p	R15C	0	.	.	43	45	CGC	117	119	CGC	37;38;37	C;G;C	37;38;37	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	313	99.04	nfsA.l15.c30.ctg.1	582	15.9	1	SNP	p	S33R	0	.	.	97	99	AGC	171	173	AGC	11;10;10	A;G;C	11;10;10	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	419	99.05	nfsA.l15.c30.ctg.2	779	13.8	0	.	p	.	0	I117T	NONSYN	349	351	ATC	227	229	ACC	29;30;30	A;C;C	29;30;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	419	99.05	nfsA.l15.c30.ctg.2	779	13.8	0	.	p	.	0	G187D	NONSYN	559	561	GGC	437	439	GAC	14;14;13	G;A;C	14;14;13	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	419	99.05	nfsA.l15.c30.ctg.2	779	13.8	1	SNP	p	G131D	0	.	.	391	393	GGC	269	271	GGC	21;20;19	G;G;C	21;19;19	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	419	99.05	nfsA.l15.c30.ctg.2	779	13.8	1	SNP	p	R203C	0	.	.	607	609	CGT	485	487	CGT	20;21;21	C;G;T,G	20;21;20,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	392	nfsA	723	419	99.05	nfsA.l15.c30.ctg.2	779	13.8	1	SNP	p	R203L	0	.	.	607	609	CGT	485	487	CGT	20;21;21	C;G;T,G	20;21;20,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	908	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1488	32.7	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1133	1135	GAG	30;28;27	G;A;G	30;27;27	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	908	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1488	32.7	1	SNP	p	G141E	0	.	.	421	423	GGT	620	622	GGT	44;48;49	G;G;T	44;48;49	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	908	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1488	32.7	1	SNP	p	G141D	0	.	.	421	423	GGT	620	622	GGT	44;48;49	G;G;T	44;48;49	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	908	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1488	32.7	1	SNP	p	R154A	0	.	.	460	462	CGT	659	661	CGT	55;55;55	C;G;T	55;55;54	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	908	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1488	32.7	1	SNP	p	R154D	0	.	.	460	462	CGT	659	661	CGT	55;55;55	C;G;T	55;55;54	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1768	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2645	35.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1837	1839	TCG	40;40;41	T;C;G	39;40;41	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1768	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2645	35.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2452	2454	AAC	40;38;38	A;A;C	40;38;38	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1768	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2645	35.8	1	SNP	p	A85T	0	.	.	253	255	GCG	466	468	GCG	29;29;28	G;C;G	28;26;24	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1768	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2645	35.8	1	SNP	p	D111H	0	.	.	331	333	GAT	544	546	GAT	31;30;30	G;A;T	30;30;30	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1768	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2645	35.8	1	SNP	p	S129P	0	.	.	385	387	TCC	598	600	TCC	31;33;34	T;C;C	31;33;33	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1138	parE_1	1893	1893	97.46	parE_1.l6.c30.ctg.1	2171	27.3	0	.	p	.	0	A52P	NONSYN	154	156	GCA	200	202	CCA	7;10;10	C,G;C;A	1,1;8;5	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1138	parE_1	1893	1893	97.46	parE_1.l6.c30.ctg.1	2171	27.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1472	1474	GAT	30;31;29	G;A;T	30;31;29	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1112	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1795	33.3	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1283	1285	GAT	34;33;36	G;A;T	34;33;35	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	V146F	0	.	.	436	438	GTT	635	637	GTT	50;49;49	G;T;T	50;49;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1736	1738	CAG	38;38;37	C;A;G	38;38;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1736	1738	CAG	38;38;37	C;A;G	38;38;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1775	1777	CAC	38;38;38	C;A;C	38;38;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1784	1786	CGT	36;38;37	C;G;T	36;38;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1784	1786	CGT	36;38;37	C;G;T	36;38;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1790	1792	TCC	42;41;40	T;C;C	42;41;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1796	1798	CTC	36;32;31	C;T,G;C	36;31,1;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1886	1888	ACC	40;40;39	A;C;C	40;40;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1889	1891	CCT	38;37;37	C;C;T	38;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3264	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4507	38.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2258	2260	CGT	61;64;64	C;G;T	61;64;64	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	.	n	.	0	A226G	SNP	226	226	A	370	370	G	251	G,A	250,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	.	n	.	0	C719T	SNP	719	719	C	863	863	T	211	T,C	101,109	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	1	SNP	n	A794T	0	.	.	794	794	A	938	938	A	215	A,G	213,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	1	SNP	n	A794G	0	.	.	794	794	A	938	938	A	215	A,G	213,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	1	SNP	n	G926C	0	.	.	926	926	G	1070	1070	G	256	G	255	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	1	SNP	n	G926T	0	.	.	926	926	G	1070	1070	G	256	G	255	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	1	SNP	n	G926A	0	.	.	926	926	G	1070	1070	G	256	G	255	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	T273A	.	273	273	T	417	417	T	235	T,A	166,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	T1010C	.	1010	1010	T	1154	1154	T	198	T,C	143,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	C183T	.	183	183	C	327	327	C	187	C,T	126,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	T90C	.	90	90	T	234	234	T	204	T,C	148,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	A250T,G	.	250	250	A	394	394	A	242	A,T,G	174,67,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	G474A	.	474	474	G	618	618	G	261	G,A	208,53	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	A253T	.	253	253	A	397	397	A	246	A,T	177,65	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	C194T	.	194	194	C	338	338	C	203	C,T	160,41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	G1002A	.	1002	1002	G	1146	1146	G	194	G,A	145,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	G1006C	.	1006	1006	G	1150	1150	G	196	G,C	142,51	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	1091	99.82	rrsB+.l15.c17.ctg.1	1235	211.7	0	HET	.	.	.	A79G	.	79	79	A	223	223	A	215	A,G	158,57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	277.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	156	A	156	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	277.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	156	A	156	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	517	277.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	156	A	156	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	116	94.02	rrsB+.l15.c17.ctg.3	116	23.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	27	27	A	46	A	43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	116	94.02	rrsB+.l15.c17.ctg.3	116	23.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	31	31	C	51	C	48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	116	94.02	rrsB+.l15.c17.ctg.3	116	23.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	35	35	C	51	C	48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	116	94.02	rrsB+.l15.c17.ctg.3	116	23.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	43	43	G	51	G	48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	116	94.02	rrsB+.l15.c17.ctg.3	116	23.2	0	.	n	.	0	.1023G	INS	1023	1023	T	48	48	G	48	G	48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8120	rrsB+	1542	116	94.02	rrsB+.l15.c17.ctg.3	116	23.2	0	.	n	.	0	C1038T	SNP	1038	1038	C	63	63	T	27	T	27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	372	soxR	465	465	100.0	soxR.l15.c17.ctg.1	825	24.3	1	SNP	p	R20H	0	.	.	58	60	CGC	228	230	CGC	43;41;41	C;G;C	42;41;41	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	372	soxR	465	465	100.0	soxR.l15.c17.ctg.1	825	24.3	1	SNP	p	G121D	0	.	.	361	363	GGT	531	533	GGT	26;26;27	G;G;T	26;26;26	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	240	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	756	16.9	1	SNP	p	A12S	0	.	.	34	36	GCA	269	271	GCA	29;29;29	G;C;A	29;29;29	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1152	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1873	33.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
